Skip to main content
. 2013 Aug 3;53(1):89–102. doi: 10.1007/s40262-013-0090-5

Table 3.

Assumptions and values used for the randomisation of factors used in the study, based on data from in vitro experiments

Factor Assumption References
CYP3A4 Log-normal distribution with a geometric SD of 1.5 (average value of the SDs reported in the literature) [68, 71, 72]
CYP2J2 Log-normal distribution with a geometric SD of 2.5 (based on the CYP2J2 mRNA distribution in postnatal liver samples) [69]
CYP-independent hydrolysis Log-normal distribution and a geometric SD of 1.3 (assumed empirical value)
Renal clearance via GFR

By use of the equation below, three normal-distributed random variables were obtained: Hill coefficient = 15 ± 0.257, TM50 = 44.4 ± 1.04 weeks, and GFRmat = 266 ± 60.7 min−1

GFR=((PMAHillTM50Hill+PMAHill·(1GFRpremat))+GFRpremat)·VolumeKidney·GFRmat

[70]
Active renal secretion via kidney P-gp transportera Log-normal distribution and a geometric SD of 1.3 [62]
Gastric emptying time in the fasted state Log-normal distribution with a geometric SD of 1.6 (based on data of more than 100 experimental gastric emptying profiles; data also used for the evaluation of the ontogeny) [48, 7375]
Gastric emptying time in the fed state

More than 100 experimental gastric emptying profiles that were obtained in healthy adults after ingestion of meals with an energy content of 593–1,051 kcal were used for the parameterisation of the gastric emptying time function of the Weibull type assuming a log-normal distribution of the parameters α and β, with geometric SDs of 1.74 in the case of α and 1.32 for β:

A(time)=A0×etimeβα

The identical randomisation was done in children

[48]
Small intestinal transit time Log-normal distribution with a geometric SD of 1.6 [7682]
Large intestinal transit time Log-normal distribution with a geometric SD of 1.6 based on literature data [83, 84]
Effective surface area of intestinal sections Log-normal distribution with a geometric SD of 1.6 (applies to all intestinal sections) [85, 86]

aRivaroxaban is a P-gp substrate

A amount of drug/volume of meal, A 0 initial amount of drug/initial amount of meal, α optimised parameter depending on meal energy content (kcal), β optimisation parameter related to the fraction of solid components of the meal, CYP cytochrome P450, e exponent, GFR glomerular filtration rate, GFR mat GFR after maturity, GFR premat GFR during development, P-gp P-glycoprotein, PMA postmenstrual age, SD standard deviation, TM 50 maturation half time